FDA Inspection 749015 — Wisconsin Pharmacal Company

Wisconsin Pharmacal Company — FEI 2124143

The FDA completed an inspection of Wisconsin Pharmacal Company on Oct 12, 2011 in Jackson, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 10 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 12, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jackson, WI (United States)

Citations

IDCFRDescription
1472021 CFR 820.50(a)(3)Acceptable supplier records, inadequate records
1472221 CFR 820.40Procedures not adequately established or maintained
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
237121 CFR 820.30(a)Design control - no procedures
310221 CFR 820.30(h)Design transfer - Lack of or inadequate procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
317221 CFR 820.198(c)Investigation of device failures
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
341521 CFR 820.22Quality Audit/Reaudit - conducted
53721 CFR 820.70(a)Production processes

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.